Skip to content

Insider · CIK 0001869579

Talat Imran

ceoofficerdirector

Files at RANI (Rani Therapeutics Holdings, Inc.). First filing Dec 10, 2024, latest Dec 10, 2024.

Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
1 / 0
$20k bought, $0 sold

Where the trades landed

Last year at the company this insider has traded most, with each buy and sell on the bar it happened.

RANI: Rani Therapeutics Holdings, Inc.

RANIOct 9, 2026 · close 0.80

Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™

Signals

This insider’s open-market buys and sells, scored.

ScoreCompanyValueHoldingsPrice contextFiled
33Weak
RANIbuy 2
Rani Therapeutics Holdings, Inc.
$20k
10,296 shares
+2%-

Transactions

Every row this insider has filed, newest first.

DateCompanyTransactionSharesPriceValueHoldings afterFiled
Sep 27, 2026RANI
Rani Therapeutics Holdings, Inc.
FTax withholding
Class A Common Stock
-7,928$0.76$6,019461,80813 d ago
May 23, 2025RANI
Rani Therapeutics Holdings, Inc.
AGrant or award
Stock Option (Right to Buy)derivative
+1,053,000$0.00$01,053,000May 23, 2025
Dec 9, 2024RANI
Rani Therapeutics Holdings, Inc.
POpen-market purchase
Class A Common Stock
+10,296$1.94$20k494,751Dec 10, 2024

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

Talat Imran: insider trades and track record | InsiderTell